These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24892956)

  • 1. Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study.
    Toender A; Kjær SK; Jensen A
    Melanoma Res; 2014 Oct; 24(5):488-95. PubMed ID: 24892956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.
    Guitera P; Collgros H; Madronio CM; Goumas C; Mann GJ; Watts CG; Pereira AR; Armstrong BK; Drummond M; Morton RL; Scolyer RA; Menzies SW; Thompson JF; Cust AE
    Australas J Dermatol; 2019 May; 60(2):118-125. PubMed ID: 30302753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013.
    Greveling K; Wakkee M; Nijsten T; van den Bos RR; Hollestein LM
    J Invest Dermatol; 2016 Oct; 136(10):1955-1960. PubMed ID: 27349862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.
    Swetter SM; Boldrick JC; Jung SY; Egbert BM; Harvell JD
    J Invest Dermatol; 2005 Oct; 125(4):685-91. PubMed ID: 16185266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
    Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
    J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence trends of lentigo maligna and lentigo maligna melanoma in the United States from 2000 to 2019.
    Chen Q; Zheng M; Ling C
    Int J Dermatol; 2024 May; 63(5):647-654. PubMed ID: 38173361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical excision margins for melanoma in situ.
    Akhtar S; Bhat W; Magdum A; Stanley PR
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):320-3. PubMed ID: 24444795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
    Cox NH; Aitchison TC; Sirel JM; MacKie RM
    Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.
    Matas-Nadal C; Malvehy J; Ferreres JR; Boada A; Bodet D; Segura S; Salleras M; Azon A; Bel-Pla S; Bigata X; Campoy A; Curcó N; Dalmau J; Formigon M; Gonzalez A; Just M; Llistosella E; Nogues ME; Pedragosa R; Pujol JA; Sabat M; Smandia JA; Zaballos P; Puig S; Martí RM
    Int J Dermatol; 2019 May; 58(5):577-581. PubMed ID: 30548854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
    Iorizzo LJ; Chocron I; Lumbang W; Stasko T
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
    Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
    Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study.
    Higgins HW; Cho E; Weinstock MA; Li TY; Qureshi A; Li WQ
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1268-1271. PubMed ID: 30451319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.
    Jaimes N; Marghoob AA; Rabinovitz H; Braun RP; Cameron A; Rosendahl C; Canning G; Keir J
    J Am Acad Dermatol; 2015 Jun; 72(6):1027-35. PubMed ID: 25824275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
    Whiteman DC; Bray CA; Siskind V; Green AC; Hole DJ; Mackie RM
    Eur J Cancer Prev; 2008 Jun; 17(3):243-50. PubMed ID: 18414196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentigo maligna melanoma--the review.
    Situm M; Bolanca Z; Buljan M
    Coll Antropol; 2010 Apr; 34 Suppl 2():299-301. PubMed ID: 21305747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentigo maligna and superficial spreading melanoma are different in their in situ phase: an immunohistochemical study.
    Auslender S; Barzilai A; Goldberg I; Kopolovic J; Trau H
    Hum Pathol; 2002 Oct; 33(10):1001-5. PubMed ID: 12395373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentigo maligna.
    Smalberger GJ; Siegel DM; Khachemoune A
    Dermatol Ther; 2008; 21(6):439-46. PubMed ID: 19076621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
    Bene NI; Healy C; Coldiron BM
    Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.